Bahl & Gaynor Inc Baxter International Inc Transaction History

Bahl & Gaynor Inc

$17.9 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$39.98 - $47.68 $106,826 - $127,400	-2,672 Reduced 28.56%	6,683 $304,000
Q1 2023 May 03, 2023	SELL	$37.58 - $52.57 $460,956 - $644,823	-12,266 Reduced 56.73%	9,355 $379,000
Q4 2022 Feb 10, 2023	SELL	$49.7 - $57.71 $941,467 - $1.09 Million	-18,943 Reduced 46.7%	21,621 $1.1 Million
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $10.2 Million - $12.6 Million	-188,918 Reduced 82.32%	40,564 $2.19 Million
Q2 2022 Aug 08, 2022	SELL	$63.83 - $80.0 $11.7 Million - $14.7 Million	-184,042 Reduced 44.51%	229,482 $14.7 Million
Q1 2022 May 12, 2022	SELL	$76.85 - $89.45 $6.28 Million - $7.31 Million	-81,745 Reduced 16.51%	413,524 $32.1 Million
Q4 2021 Feb 10, 2022	SELL	$74.57 - $87.19 $6.48 Million - $7.58 Million	-86,915 Reduced 14.93%	495,269 $42.5 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $6.33 Million - $7.18 Million	85,854 Added 17.3%	582,184 $46.8 Million
Q2 2021 Aug 06, 2021	SELL	$80.5 - $88.01 $333,109 - $364,185	-4,138 Reduced 0.83%	496,330 $40 Million
Q1 2021 May 11, 2021	SELL	$76.38 - $86.03 $554,824 - $624,921	-7,264 Reduced 1.43%	500,468 $42.2 Million
Q4 2020 Feb 02, 2021	SELL	$75.39 - $82.36 $12.4 Million - $13.5 Million	-164,264 Reduced 24.44%	507,732 $40.7 Million
Q3 2020 Nov 12, 2020	SELL	$78.33 - $90.73 $155,563 - $180,189	-1,986 Reduced 0.29%	671,996 $54 Million
Q2 2020 Aug 13, 2020	BUY	$78.66 - $94.14 $1.02 Million - $1.22 Million	12,908 Added 1.95%	673,982 $58 Million
Q1 2020 May 26, 2020	BUY	$71.57 - $93.3 $38.5 Million - $50.2 Million	538,381 Added 438.8%	661,074 $53.7 Million
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $37.8 Million - $49.2 Million	-527,512 Reduced 81.13%	122,693 $9.96 Million
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $275,429 - $317,623	-3,591 Reduced 0.55%	650,205 $54.4 Million
Q3 2019 Nov 14, 2019	BUY	$81.4 - $89.78 $80,830 - $89,151	993 Added 0.15%	653,796 $57.2 Million
Q2 2019 Aug 12, 2019	BUY	$73.44 - $82.41 $4.7 Million - $5.27 Million	63,999 Added 10.87%	652,803 $53.5 Million
Q1 2019 May 13, 2019	BUY	$64.48 - $81.31 $3.57 Million - $4.5 Million	55,402 Added 10.39%	588,804 $47.9 Million
Q4 2018 Feb 12, 2019	BUY	$61.45 - $77.8 $7.61 Million - $9.63 Million	123,765 Added 30.21%	533,402 $35.1 Million
Q3 2018 Nov 09, 2018	BUY	$70.71 - $77.75 $16.6 Million - $18.3 Million	235,093 Added 134.69%	409,637 $31.6 Million
Q2 2018 Aug 14, 2018	BUY	$63.43 - $75.41 $9.93 Million - $11.8 Million	156,556 Added 870.34%	174,544 $12.9 Million
Q1 2018 May 11, 2018	SELL	$62.56 - $72.26 $21,520 - $24,857	-344 Reduced 1.88%	17,988 $1.17 Million
Q4 2017 Feb 13, 2018	BUY	$61.45 - $66.05 $310,076 - $333,288	5,046 Added 37.98%	18,332 $1.19 Million
Q3 2017 Nov 13, 2017	SELL	$59.5 - $64.61 $112,574 - $122,242	-1,892 Reduced 12.47%	13,286 $834,000
Q2 2017 Aug 11, 2017	SELL	N/A	-5,762 Reduced 27.52%	15,178 $919,000
Q2 2017 Aug 10, 2017	BUY	N/A	20,940	20,940 $928,000

Others Institutions Holding BAX

# of Institutions

998

Shares Held

450M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account